If each cancer cell produces on average more than one cancer cell, we see a net growth of the tumors and metastases and vice versa. We review recent clinical results for microsatellite stable metastatic colorectal cancer (MSS-mCRC) suggesting immunotherapy combinations with personalized vaccines, checkpoint inhibitors, targeted therapies, multikinase inhibitors, chemotherapies, and radiation that simultaneously slow cancer cell growth rate and enhance T cell killing rate of cancer cells may in future synergize to control the disease.
CITATION STYLE
Srikrishna, D., & Sachsenmeier, K. (2021). We need to bring R0 < 1 to treat cancer too. Genome Medicine, 13(1). https://doi.org/10.1186/s13073-021-00940-9
Mendeley helps you to discover research relevant for your work.